Gemtuzumab ozogamicin (fractionated regimen)

gemtuzumab ozogamicin · Wyeth (original); under development context in trial

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gemtuzumab ozogamicin (fractionated regimen), covering 2026-07-23 to 2026-07-23. Get the full timeline:

Most recent: Clinical Trial Results: Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]

See pricing